Los Angeles, CA, August 12, 2014 --(PR.com
)-- AIDS Research Alliance (ARA) is pleased to announce an expansion of its services to include the ability to conduct leukapheresis, and to provide leukopaks to research and pharmaceutical institutions.
Founded in 1989, ARA has been conducting clinical trials for 25 years, and has conducted over 150 trials to date. With its own outreach program, ARA is able to recruit study volunteers with specific medical conditions or diseases. Additionally, ARA has its own Institutional Review Board (IRB), enabling it to expedite studies, including the collection of leukopaks for other institutions’ specialized research purposes.
Under the expert supervision of ARA’s Scientific Director, Stefanie Homann, Ph.D., ARA’s research staff is currently collecting white blood cells from HIV-positive study volunteers, as well as from study volunteers with Hepatitis B and C. Because ARA has its own outreach program, the organization is ready to recruit and collect blood products from study volunteers with any requested medical condition.
“We are pleased to unveil our new clinical capacity -- leukapheresis,” said Stefanie Homann, Ph.D. “We look forward to working with various members of the research and pharmaceutical communities to provide them with fresh blood products, so that they may advance their own research.”
For more information, please email firstname.lastname@example.org
AIDS Research Alliance is a nonprofit, medical research organization dedicated to finding a cure for AIDS. Since 1989, AIDS Research Alliance has conducted clinical trials leading to the approval of half of today’s HIV/AIDS treatments. Its current research targeting latent HIV reservoirs, including the development of prostratin, will bring the world closer to a cure. Free from political or profit motives, AIDS Research Alliance offers clinical trial volunteers access to the next generation of HIV/AIDS treatments and vaccines at its world-class clinic in downtown Los Angeles, and in this way, pursues all pathways to the worldwide eradication of HIV/AIDS. For more information, visit www.aidsresearch.org.